Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Glimepiride in T2D with Subclinical Heart Failure
NCT01425580Phase 2Completed
- Start
- Jan 2012
- Primary completion
- Aug 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in heart failure (HF), type 2 diabetes mellitus (T2DM). Started Jan 2012; status: completed.
02
Drugs
03
Conditions
heart failure (HF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01425580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425580.